Will Canopy Growth stock stabilize as seller pressure dominates?

Traders Union
All News
Stocks
Canopy Growth drops 6.6% to $0.71

Highlights

Canopy Growth's Smiths Falls facility obtained EU GMP certification, permitting legal export of cannabis products to EU markets.
The site is now Canada's only facility combining softgel manufacturing with primary packaging for multiple cannabis product forms.
Shares of Canopy Growth trade below key moving averages with persistent bearish momentum and are expected in a $0.65 to $0.77 range over the next 2 to 3 days.

EU GMP certification expands export potential despite sustained market pressure

Canopy Growth Corporation's Smiths Falls, Ontario facility has received European Union Good Manufacturing Practice (EU GMP) certification for manufacturing and packaging activities, according to Canopygrowth. This regulatory approval enables Canopy Growth to legally export and distribute softgels, oral liquids, and dried cannabis flower to EU markets, broadening its access and positioning the company for potential new revenue streams. Certification as Canada’s only site to combine softgel manufacturing with primary packaging for multiple product forms may improve operational competitiveness, though price action has remained under broader selling pressure.

Downside momentum intensifies as CGC breaches all major technical supports

CGC is trading below the MA-20 at $0.76 and MA-50 at $0.82 on the hourly chart, as well as below the MA-200 at $1.03 on the daily timeframe. The Ichimoku Kijun stands at $0.79 as immediate resistance. Momentum readings are strongly negative, with MACD and ADX both flashing Sell signals. RSI is deep in oversold territory at 24.42, matched by oversold conditions in both CCI and Stochastic RSI. Bull/Bear Power confirms intraday seller dominance, while the Awesome Oscillator shows a neutral signal but does not offset the overall downside bias.

Near-term downside risk elevated as upward reversal remains unlikely

Over the next 2–3 trading days, CGC is expected to remain volatile within a range of $0.65 to $0.77. The probability of a near-term upward reversal is considered very low, while a continued move lower carries a high likelihood. The baseline scenario is for stabilization within the current range; a bullish case would require a break above $0.79 to trigger a short-term recovery, while a bearish scenario could see the price extend its decline below $0.65.

Viktoras Karapetjanc, expert at Traders Union, believes Canopy Growth’s EU GMP certification is a constructive regulatory milestone that could support future growth and market access. However, he notes that current market sentiment is still dominated by selling pressure, as shown by continued weakness below major moving averages and oversold technical conditions. A sustained recovery will require notable improvement in price action and a shift in momentum. 'The latest certification is a win for Canopy’s fundamentals, but I need to see the price reclaim $0.79 before taking a more constructive view on the stock.'

Earlier, analysts noted that Canopy Growth was exhibiting persistent bearish momentum, with technical indicators pointing to continued downside risk. The current analysis further strengthens this negative outlook, highlighting a prevailing downside bias and signaling that traders should closely monitor the $0.65 level for potential further declines.

Source of Data: CGC Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.